Home › Funds › INGALLS & SNYDER LLC › OMER
INGALLS & SNYDER LLC position in OMER
OMEROS CORP · Health Care
INGALLS & SNYDER LLC reported holding 3,095,323 shares of OMER (OMEROS CORP) in its Q3 2026 13F filing — a position valued at US$58.9M, representing 2.04% of its reported portfolio and ranking #10 among its reported holdings. INGALLS & SNYDER LLC has disclosed OMER holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How INGALLS & SNYDER LLC's OMER position evolved
INGALLS & SNYDER LLC first disclosed a stake in OMER in Q3 2023 at 30,000 shares (US$88K). The position peaked in Q3 2026 at 3,095,323 shares, worth US$58.9M. Across 13 filings, INGALLS & SNYDER LLC increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 3,095,323 shares valued at US$58.9M — a reduction of -564,200 shares quarter over quarter.. Notable position changes include a 6310% increase in Q1 2024 (shares rose 18% over the following quarter), a 1179% increase in Q4 2025 (shares fell 39% over the following quarter), a 547% increase in Q1 2026 (shares fell 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 30.00K | $88.00K | New |
| Q4 2023 | 10.00K | $33.00K | Reduce |
| Q1 2024 | 641.00K | $463.00K | Add |
| Q2 2024 | 641.00K | $450.00K | Hold |
| Q3 2024 | 641.00K | $435.00K | Hold |
| Q4 2024 | 1.55M | $1.46M | Add |
| Q1 2025 | 1.53M | $1.41M | Reduce |
| Q2 2025 | 1.53M | $1.48M | Hold |
| Q3 2025 | 43.00K | $176.00K | Reduce |
| Q4 2025 | 550.00K | $550.00K | Add |
| Q1 2026 | 3.56M | $37.59M | Add |
| Q2 2026 | 3.66M | $34.80M | Add |
| Q3 2026 | 3.10M | $58.94M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About OMER and 13F data
OMER (OMEROS CORP) is a Health Care company. 39 other funds we track also report a position in OMER — the largest reported positions include Context Capital Management, LLC (US$28.3M), Clutterbuck Capital Management LLC (US$7.1M), Virtus Investment Advisers, LLC (US$3.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding OMER
- Context Capital Management, LLC 8.71M sh · $28.30M · Q3 2026
- Clutterbuck Capital Management LLC 375.00K sh · $7.14M · Q3 2026
- Virtus Investment Advisers, LLC 192.96K sh · $3.67M · Q3 2026
More on INGALLS & SNYDER LLC
FAQ
How long has INGALLS & SNYDER LLC held OMER?
INGALLS & SNYDER LLC has disclosed OMER holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is INGALLS & SNYDER LLC's current position in OMER?
As of Q3 2026, INGALLS & SNYDER LLC holds 3.10M shares of OMER (OMEROS CORP), valued at $58.94M, representing 2.04% of its reported portfolio and ranking #10.
Has INGALLS & SNYDER LLC been buying or selling OMER?
In the latest 13F filing (Q3 2026), INGALLS & SNYDER LLC reduced its position in OMER. The position peaked in Q3 2026 at 3.10M shares.
Which other funds hold OMER?
Other major institutional holders of OMER include Context Capital Management, LLC, Clutterbuck Capital Management LLC, Virtus Investment Advisers, LLC, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.